Cargando…
The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
OBJECTIVE: Thyroid peroxidase antibody (TPOAb), the most common antibody frequently measured in population surveys is a protein expressed in the thyroid gland. We conducted the present study to analyze the prevalence and incidence of thyroid auto immunity and natural course of TPOAb in a population...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215694/ https://www.ncbi.nlm.nih.gov/pubmed/28052092 http://dx.doi.org/10.1371/journal.pone.0169283 |
_version_ | 1782491803825471488 |
---|---|
author | Amouzegar, Atieh Gharibzadeh, Safoora Kazemian, Elham Mehran, Ladan Tohidi, Maryam Azizi, Fereidoun |
author_facet | Amouzegar, Atieh Gharibzadeh, Safoora Kazemian, Elham Mehran, Ladan Tohidi, Maryam Azizi, Fereidoun |
author_sort | Amouzegar, Atieh |
collection | PubMed |
description | OBJECTIVE: Thyroid peroxidase antibody (TPOAb), the most common antibody frequently measured in population surveys is a protein expressed in the thyroid gland. We conducted the present study to analyze the prevalence and incidence of thyroid auto immunity and natural course of TPOAb in a population based study. MATERIAL AND METHODS: This prospective study was conducted within the framework of the Tehran Thyroid Study (TTS) on 5783 (2376 men and 3407 women) individuals aged ≥ 20 years who had thyroid function tests at baseline and were followed up for median 9.1 year with TPOAb measurements at approximately every 3 years. RESULTS: The mean age of total population at baseline was 40.04±14.32. At baseline, of the 5783 participants, 742 (12.8%) were TPOAb positive, with higher prevalence among women than in men (16.0 vs. 8.5%, p = 0.001). The prevalence of TPOAb positivity in the total population was 11.9, 14.9 and 13.6% in the young, middle age and elderly respectively. The total incidence rate (95%CI) of TPOAb positivity in the total population (5020) was 7.1 (6.36–7.98) per 1000 person-years of follow-up, with higher incidence of TPOAb positivity among young participants, i.e. 8.5 (7.5–9.7) per 1000 person-years. Sex specific incidence rate demonstrated that TPOAb positivity was higher in women, 9.3 (8.2–10.7) per 1000 person-years. The Cox's proportional hazard model analysis showed that the hazard ratio of developing TPOAb positivity was higher in women than men (P<0.0001) and tended to increase slightly with serum TSH levels (P<0.0001) but declined with increasing age (P<0.0001) in the total population. Our findings demonstrate that individuals, who became TPOAb positive in each phase, had significant elevation of TSH levels at the phase of seroconversion, compared to baseline values. CONCLUSION: Gender, age and elevated serum TSH were found to be risk factors for developing TPOAb positivity. Furthermore, compared to baseline a significant elevation of TSH levels during seroconversion phase was observed in TPOAb positive individuals. |
format | Online Article Text |
id | pubmed-5215694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-52156942017-01-19 The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study Amouzegar, Atieh Gharibzadeh, Safoora Kazemian, Elham Mehran, Ladan Tohidi, Maryam Azizi, Fereidoun PLoS One Research Article OBJECTIVE: Thyroid peroxidase antibody (TPOAb), the most common antibody frequently measured in population surveys is a protein expressed in the thyroid gland. We conducted the present study to analyze the prevalence and incidence of thyroid auto immunity and natural course of TPOAb in a population based study. MATERIAL AND METHODS: This prospective study was conducted within the framework of the Tehran Thyroid Study (TTS) on 5783 (2376 men and 3407 women) individuals aged ≥ 20 years who had thyroid function tests at baseline and were followed up for median 9.1 year with TPOAb measurements at approximately every 3 years. RESULTS: The mean age of total population at baseline was 40.04±14.32. At baseline, of the 5783 participants, 742 (12.8%) were TPOAb positive, with higher prevalence among women than in men (16.0 vs. 8.5%, p = 0.001). The prevalence of TPOAb positivity in the total population was 11.9, 14.9 and 13.6% in the young, middle age and elderly respectively. The total incidence rate (95%CI) of TPOAb positivity in the total population (5020) was 7.1 (6.36–7.98) per 1000 person-years of follow-up, with higher incidence of TPOAb positivity among young participants, i.e. 8.5 (7.5–9.7) per 1000 person-years. Sex specific incidence rate demonstrated that TPOAb positivity was higher in women, 9.3 (8.2–10.7) per 1000 person-years. The Cox's proportional hazard model analysis showed that the hazard ratio of developing TPOAb positivity was higher in women than men (P<0.0001) and tended to increase slightly with serum TSH levels (P<0.0001) but declined with increasing age (P<0.0001) in the total population. Our findings demonstrate that individuals, who became TPOAb positive in each phase, had significant elevation of TSH levels at the phase of seroconversion, compared to baseline values. CONCLUSION: Gender, age and elevated serum TSH were found to be risk factors for developing TPOAb positivity. Furthermore, compared to baseline a significant elevation of TSH levels during seroconversion phase was observed in TPOAb positive individuals. Public Library of Science 2017-01-04 /pmc/articles/PMC5215694/ /pubmed/28052092 http://dx.doi.org/10.1371/journal.pone.0169283 Text en © 2017 Amouzegar et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Amouzegar, Atieh Gharibzadeh, Safoora Kazemian, Elham Mehran, Ladan Tohidi, Maryam Azizi, Fereidoun The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study |
title | The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study |
title_full | The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study |
title_fullStr | The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study |
title_full_unstemmed | The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study |
title_short | The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study |
title_sort | prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: tehran thyroid study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215694/ https://www.ncbi.nlm.nih.gov/pubmed/28052092 http://dx.doi.org/10.1371/journal.pone.0169283 |
work_keys_str_mv | AT amouzegaratieh theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT gharibzadehsafoora theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT kazemianelham theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT mehranladan theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT tohidimaryam theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT azizifereidoun theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT amouzegaratieh prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT gharibzadehsafoora prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT kazemianelham prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT mehranladan prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT tohidimaryam prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy AT azizifereidoun prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy |